Axitinib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in people who have not been treated successfully with another medication. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
Inlyta is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in people who have not been treated successfully with another medication. Axitinib is in a class of medications called kinase inhibitors.
It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Inlyta (Axitinib) Tablets suppliers in India. Allevaire India New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
Alleviare Life Sciences connects the buyer with the supplier who can ship Inlyta (Axitinib) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Inlyta (Axitinib) is manufactured by Pfizer.
Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The order for Inlyta (Axitinib) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
INLYTA is indicated for the treatment of advanced renal cell carcinoma (RCC) after the failure of one prior systemic therapy.
Limitation of Use:
INLYTA is a prescription medicine used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC) when one prior drug treatment for this disease has not worked. It is not known if INLYTA is safe or effective in children.
Medicine Name: Inlyta
Generic Name: Axitinib
Approval Date: 09/06/2013
Company Name: Pfizer.
Available as (Form & Strength): 1 mg and 5 mg Tablets
Inlyta is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Inlyta (Axitinib) Tablets on prescription and Import License in Patient’s Name only.
For foreign countries patients, Inlyta (Axitinib) Tablets can be made available in Send your inquiry to find Inlyta (Axitinib) Tablets in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Inlyta (Axitinib) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details